This study is on patients with severe multivessel disease and ischemic cardiomyopathy. Do they have significant improvement in their LV function after local delivery of autologous skeletal myoblasts?

High-dose chemotherapy with autologous stem cell support (HDT) has been proven effective in relapsed aggressive non-Hodgkin lymphoma (NHL). However, conflicting results of HDT as part of first-line ...